Techne (TECH) Stock Research, Analysis & News

Quick Analysis on Techne (TECH) Stock as of January 29, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Techne (TECH) Stock below)

Techne (TECH) Stock Profile Summary

TECHNE Corporation and its subsidiaries engage in the development, manufacture, and sale of biotechnology products, and hematology calibrators and controls primarily in the United States and Europe. The companys biotechnology product line includes Cytokines, extracted from natural sources or produced using recombinant DNA technology; Enzymes and related factors, including enzyme substrates and inhibitors; antibodies, proteins produced by the immune system of an animal; assay kits, such as human and animal Quantikine kits, which allow research scientists to quantify the amount of a specific analyte; clinical diagnostic kits, including erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassays; flow cytometry products consisting of fluorochrome labeled antibodies and Fluorokine kits, which measure the presence or absence of cell surface receptors for specific cytokines by flow cytometry; and intracellular cell signaling products, including antibodies, phospho-specific antibodies, antibody protein arrays, active caspases, kinases, phosphatases, and ELISA assays. Its hematology product line comprises whole blood CBC controls/calibrators; linearity and reportable range controls that provide a means of assessing the linearity of hematology analyzers for white blood cells, red blood cells, platelets, and reticulocytes; whole blood reticulocyte controls for manual and automated counting of reticulocytes; whole blood flow cytometry controls for flow cytometry instruments; whole blood glucose/hemoglobin control to monitor instruments which measure glucose and hemoglobin in whole blood; erythrocyte sedimentation rate control to monitor erythrocyte sedimentation rate tests; and multi-purpose platelet reference controls for use by automated and semi-automated analyzers. TECHNE Corporation sells its products to research and clinical diagnostics markets. The company was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Techne (TECH) Stock Key Statistics Research and Analysis as of January 29, 2020

Techne (TECH) Stock Competitor Research and Analysis

Life Technologies Corporation (LIFE)Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)Novartis AG (NVS)
AstraZeneca PLC (AZN)Abbott Laboratories (ABT)

Mutual Funds with Techne (TECH) Stock in its top 10 holdings

FundCategoryTECH Holding Percentage
Alger Small Cap Growth I-2Small Growth2.01%
Alger Small Cap Growth Institutional ISmall Growth2.15%
Alger Growth Opportunities ASmall Growth3.52%
Alger Small Cap Growth Institutional RSmall Growth2.15%
Delaware Pooled Focus Smid-Cap Gr EqMid-Cap Growth4.93%
Delaware Smid Cap Growth CMid-Cap Growth4.92%

ETFs with Techne (TECH) Stock in its top 10 holdings

Stock Research on Techne (TECH)

Latest Market News on Techne (TECH)

Click here to find the latest news on Techne (TECH)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Life Technologies Corporation (LIFE)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)